ATM and cervical carcinoma: Other investigations have reported enhanced radiosensitivity by inhibition of ATM in several malignancies.45–49 Although ATM inhibitors are still in pre-clinical development, our study suggests relevance of ATM-targeted agents and warrants a further assessment of ATM inhibition as a (chemo)radiosensitising treatment in patients with advanced-stage cervical cancer.